C0014912||Estradiol
C0033262||prodrugs
C0033262||Estradiol prodrugs
C0001563||oral
C0014939||estrogen
C0232741||liver functions
C0001563||Oral
C0205054||hepatic
C0877035||estrogenic effects
C0023779||lipids
C0019116||hemostatic factors
C0037663||GH
C0021665||IGF I
C0003017||angiotensinogen
C0001563||oral treatment
C0014912||estradiol
C0014912||E2
C0033262||prodrugs
C0033262||Estradiol prodrugs
C0736268||liver tissue
C0014912||E2
C0014912||EC508
C0007034||carbonic anhydrase II
C0007034||carbonic anhydrase II
C1149286||binding
C0007034||CA II
C0014792||erythrocytes
C0033262||Estradiol prodrugs
C2324289||portal vein blood
C0023884||liver
C0439799||passage
C0034721||rats
C0001563||orally treated
C0042149||Uteri
C3827964||weighed
C0201950||Cholesterol fractions
C0523500||angiotensinogen
C0032105||plasma
C0015011||ethinyl estradiol
C0015011||ethinyl estradiol
C0042149||uterine
C0018270||growth
C0205054||hepatic
C0877035||estrogenic effects
C0033262||Estradiol prodrugs
C1326619||uterine growth
C0032105||plasma
C0008377||cholesterol
C0003017||angiotensinogen
C0201734||pharmacokinetic studies
C0014912||EC508
C0013125||intravenous
C0001563||oral administration
C0034721||rats
C0001563||oral
C0005767||blood
C0032105||plasma
C0014792||erythrocyte
C0014912||EC508
C1515655||in vivo
C0023884||liver
C0439799||passage
C0014939||estrogenicity
C0205054||hepatic
C0877035||estrogenic effects
C0014912||E2
C0033262||sulfonamide EP
C0001563||oral
C0033262||Estradiol prodrugs
C0023884||liver
C0014792||erythrocytes
C0014912||estradiol
C0205054||hepatic
C0001563||oral
C0279494||estrogen therapy